AAN's Behavioral Neurology Section Group provides recommendations for improving clinical cognitive testing

NewsGuard 100/100 Score

Recommendations for improving clinical cognitive testing were reported by the American Academy of Neurology's (AAN) Behavioral Neurology Section (BNS) Group, led by Kirk R. Daffner, MD, of Boston, Mass. The Group focused on the Neurobehavioral Status Exam (NBSE), conducting evidence-based reviews of testing used for five domains - attention, language, memory, spatial cognition, and executive function). "Improving clinical cognitive testing" (doi: 10.1212/WNL.0000000000001763) was published online ahead of print on July 10, 2015, in Neurology, the official journal of the AAN.

While the NBSE is used to determine the differential diagnoses and guide intervention, there are no guidelines for selecting tests to include in an NBSE, and little information on how it is used in clinical practive. The NBSE Workgroup was formed to review use of the NBSE in office-based clinical practice, toward the goal of quality improvement in cognitive assessment. Data were collected from 200 AAN-BNS members who conduct NBSE. Responses were reviewed by experts in each of the five domains.

"This survey is an important step in our knowledge of how behavioral neurologists apply single-domain cognitive testing in their practices," said A.M. Barrett, MD, of Kessler Foundation, director of the subgroup on spatial cognition tests. "This evidence-based evaluation of commonly used tests provides insights that will inform the decision making process for selecting tests for the NBSE."

Source: Kessler Foundation

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New treatments in sight for challenging neuropsychiatric symptoms in neurodegenerative diseases